Workflow
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of iTeos Therapeutics, Inc.

Core Viewpoint - Rowley Law PLLC is investigating potential securities law violations related to the proposed acquisition of iTeos Therapeutics, Inc. by Concentra Biosciences, LLC, with stockholders set to receive $10.047 and one contingent value right for each share held [1]. Group 1 - The proposed acquisition transaction is expected to close in the third quarter of 2025 [1]. - Stockholders of iTeos Therapeutics will receive a total of $10.047 per share along with one contingent value right [1].